Topcon Medical Systems, Inc.
Paramus, NJ, September 21, 2009 – Topcon Medical Systems Inc. and Tracey Technologies Corp., announced today that they have entered into an exclusive distributorship agreement for iTrace, Tracey’s innovative ray tracing aberrometer/topographer.
Under the terms of the agreement, Topcon, the leading supplier of ophthalmic diagnostic equipment and image management solutions will be the sole distributor for two iTrace product versions, the iTrace Combo and the iTrace Solo, to optometrists and ophthalmologists within the US. The iTrace utilizes superior ‘raytracing’ technology that delivers an advanced and accurate methodology of analyzing the eye’s total optical performance, to improve clinical efficiencies. Additionally, the iTrace has the unique advantage of open field fixation to objectively measure accommodation and to overcome instrument myopia. The iTrace Combo, an integrated 5‐in‐1 product combines an auto‐refractor, corneal topographer, wavefront analyzer, pupillometer and auto‐keratometer; while the 3‐in‐1 iTrace Solo combines a wavefront analyzer, autorefractor and pupillometer. Both products save practitioners time, space and cost.
Paul Karpecki, Optometrist and Clinical Director at the Koffler Vision Group is very positive about iTrace and the partnership between the two companies. “I have incorporated the iTrace in my practice and am impressed with its applicability in enabling my decision‐making process. Rather than merely delivering diagnostics, the iTrace goes a step further and helps doctors understand the applicability of the data in selecting surgery options for patients.”
According to Refractive Surgeon, Dan Durrie, MD of Durrie Vision, “this is a best‐fit collaboration between two leaders in their respective areas of ophthalmic technology and diagnostic solutions. The industry is headed in the direction of integrated processes and the iTrace offers a premium, easy‐to‐use measurement device at a competitive price. “
This partnership will further reinforce Topcon’s leadership position and strengthen Tracey’s presence in the market, simultaneously increasing awareness and understanding of the iTrace. Ophthalmologist John Hunkeler, MD and Chairman at Tracey is extremely optimistic, ‘I look at this agreement as an opportunity for Topcon and Tracey to synergize sales, marketing and technology skill sets. This partnership will pave the
way for a strong relationship that will enable our customers to deliver superior, cost‐effective treatments to their patients.”
Vice President ‐ Marketing at Topcon Katrin Teigeler states, “Topcon strives to introduce innovative technologies into the US market. The iTrace complements our current offering and we look to expanding its clinical utility in close collaboration with Tracey and its co‐founder Dr. Joe Wakil.”
About Topcon Medical Systems, Inc.
Based in Paramus, NJ, Topcon Medical Systems (TMS) is a leader and technical innovator in the field of ophthalmic instrumentation. For over 37 years, TMS has offered the most complete and technically advanced line of ophthalmic equipment in the US marketplace. This equipment comprises the largest selection of precision ophthalmic and optical instruments from one manufacturer, providing a complete range of products for general and specialized applications. TMS manages ophthalmic dealer sales, corporate sales, and the Advanced Technology Products Division. TMS is a division of Topcon America Corporation, a wholly owned subsidiary of Topcon Corporation of Tokyo, Japan.
About Tracey Technologies, Inc.
Founded in August of 1999, Tracey Technologies is a technology leader in the newly emerging field of “Wavefront Aberrometry.” Tracey’s unique point‐by‐point ray tracing aberrometer, iTrace is a proprietary, cost‐effective technology well positioned to be a market leader in this emerging industry. The iTrace system’s ability to measure accommodative volume is now expanding its clinical use to include the rapidly developing market for multi‐focal and accommodating IOLs.